APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phentolamine Mesylate Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Phentolamine Mesylate Injection Market Outlook and Growth Opportunities 2026

29 December 2025199 pages

Choose your research edition.

Industry ResearchPhentolamine Mesylate Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Phentolamine Mesylate Injection Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Phentolamine Mesylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phentolamine Mesylate Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Phentolamine Mesylate Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Phentolamine Mesylate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Phentolamine Mesylate Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Phentolamine Mesylate Injection market include Hikma, Precision Dose, Septodont, Hainan Poly Pharm, CR Double-Crane, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals and Sichuan Meida Kangjiale Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Phentolamine Mesylate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phentolamine Mesylate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phentolamine Mesylate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Phentolamine Mesylate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Phentolamine Mesylate Injection Segment by Company

Hikma

Precision Dose

Septodont

Hainan Poly Pharm

CR Double-Crane

Sunflower Pharmaceutical

Shanghai Fudan Forward Pharmaceuticals

Sichuan Meida Kangjiale Pharmaceutical

Phentolamine Mesylate Injection Segment by Type

Intravenous Injection

Intramuscular Injection

Phentolamine Mesylate Injection Segment by Application

Hospital and Clinic

Pharmacy

Other

Phentolamine Mesylate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Phentolamine Mesylate Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Phentolamine Mesylate Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Phentolamine Mesylate Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Phentolamine Mesylate Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phentolamine Mesylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phentolamine Mesylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phentolamine Mesylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Phentolamine Mesylate Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phentolamine Mesylate Injection industry.

Chapter 3: Detailed analysis of Phentolamine Mesylate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Phentolamine Mesylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Phentolamine Mesylate Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Phentolamine Mesylate Injection Industry Trends Table 2. Phentolamine Mesylate Injection Industry Drivers Table 3. Phentolamine Mesylate Injection Industry Opportunities and Challenges Table 4. Phentolamine Mesylate Injection Industry Restraints Table 5. Global Phentolamine Mesylate Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Phentolamine Mesylate Injection Revenue Share by Company (2021-2026) Table 7. Global Phentolamine Mesylate Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Phentolamine Mesylate Injection Sales Volume Share by Company (2021-2026) Table 9. Global Phentolamine Mesylate Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Phentolamine Mesylate Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Phentolamine Mesylate Injection Key Company Manufacturing Base & Headquarters Table 12. Global Phentolamine Mesylate Injection Company, Product Type & Application Table 13. Global Phentolamine Mesylate Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Phentolamine Mesylate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intravenous Injection Table 18. Significant Companies of Intramuscular Injection Table 19. Global Phentolamine Mesylate Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Phentolamine Mesylate Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Phentolamine Mesylate Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Phentolamine Mesylate Injection Sales Volume Share by Type (2021-2026) Table 23. Global Phentolamine Mesylate Injection Sales Volume Share by Type (2027-2032) Table 24. Global Phentolamine Mesylate Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Phentolamine Mesylate Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Phentolamine Mesylate Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Phentolamine Mesylate Injection Sales Value Share by Type (2021-2026) Table 28. Global Phentolamine Mesylate Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Pharmacy Table 31. Significant Companies of Other Table 32. Global Phentolamine Mesylate Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Phentolamine Mesylate Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Phentolamine Mesylate Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Phentolamine Mesylate Injection Sales Volume Share by Application (2021-2026) Table 36. Global Phentolamine Mesylate Injection Sales Volume Share by Application (2027-2032) Table 37. Global Phentolamine Mesylate Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Phentolamine Mesylate Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Phentolamine Mesylate Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Phentolamine Mesylate Injection Sales Value Share by Application (2021-2026) Table 41. Global Phentolamine Mesylate Injection Sales Value Share by Application (2027-2032) Table 42. Global Phentolamine Mesylate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Phentolamine Mesylate Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Phentolamine Mesylate Injection Sales Market Share by Region (2021-2026) Table 45. Global Phentolamine Mesylate Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Phentolamine Mesylate Injection Sales Market Share by Region (2027-2032) Table 47. Global Phentolamine Mesylate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Phentolamine Mesylate Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Phentolamine Mesylate Injection Sales Value Share by Region (2021-2026) Table 50. Global Phentolamine Mesylate Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Phentolamine Mesylate Injection Sales Value Share by Region (2027-2032) Table 52. Global Phentolamine Mesylate Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Phentolamine Mesylate Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Phentolamine Mesylate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Phentolamine Mesylate Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026) Table 58. Global Phentolamine Mesylate Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Phentolamine Mesylate Injection Sales Market Share by Country (2027-2032) Table 60. Global Phentolamine Mesylate Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Phentolamine Mesylate Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Phentolamine Mesylate Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Phentolamine Mesylate Injection Sales Value Market Share by Country (2027-2032) Table 64. Hikma Company Information Table 65. Hikma Business Overview Table 66. Hikma Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Hikma Phentolamine Mesylate Injection Product Portfolio Table 68. Hikma Recent Development Table 69. Precision Dose Company Information Table 70. Precision Dose Business Overview Table 71. Precision Dose Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Precision Dose Phentolamine Mesylate Injection Product Portfolio Table 73. Precision Dose Recent Development Table 74. Septodont Company Information Table 75. Septodont Business Overview Table 76. Septodont Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Septodont Phentolamine Mesylate Injection Product Portfolio Table 78. Septodont Recent Development Table 79. Hainan Poly Pharm Company Information Table 80. Hainan Poly Pharm Business Overview Table 81. Hainan Poly Pharm Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolio Table 83. Hainan Poly Pharm Recent Development Table 84. CR Double-Crane Company Information Table 85. CR Double-Crane Business Overview Table 86. CR Double-Crane Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. CR Double-Crane Phentolamine Mesylate Injection Product Portfolio Table 88. CR Double-Crane Recent Development Table 89. Sunflower Pharmaceutical Company Information Table 90. Sunflower Pharmaceutical Business Overview Table 91. Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolio Table 93. Sunflower Pharmaceutical Recent Development Table 94. Shanghai Fudan Forward Pharmaceuticals Company Information Table 95. Shanghai Fudan Forward Pharmaceuticals Business Overview Table 96. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolio Table 98. Shanghai Fudan Forward Pharmaceuticals Recent Development Table 99. Sichuan Meida Kangjiale Pharmaceutical Company Information Table 100. Sichuan Meida Kangjiale Pharmaceutical Business Overview Table 101. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolio Table 103. Sichuan Meida Kangjiale Pharmaceutical Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Phentolamine Mesylate Injection Distributors List Table 107. Phentolamine Mesylate Injection Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Phentolamine Mesylate Injection Product Image Figure 2. Global Phentolamine Mesylate Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phentolamine Mesylate Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Phentolamine Mesylate Injection Sales (2021-2032) & (K Units) Figure 5. Global Phentolamine Mesylate Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Phentolamine Mesylate Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intravenous Injection Image Figure 10. Intramuscular Injection Image Figure 11. Global Phentolamine Mesylate Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Phentolamine Mesylate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Phentolamine Mesylate Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Phentolamine Mesylate Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Phentolamine Mesylate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Phentolamine Mesylate Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Pharmacy Image Figure 19. Other Image Figure 20. Global Phentolamine Mesylate Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Phentolamine Mesylate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Phentolamine Mesylate Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Phentolamine Mesylate Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Phentolamine Mesylate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Phentolamine Mesylate Injection Sales Value Share by Application (2021-2032) Figure 26. Global Phentolamine Mesylate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Phentolamine Mesylate Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Phentolamine Mesylate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Phentolamine Mesylate Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Phentolamine Mesylate Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Phentolamine Mesylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Phentolamine Mesylate Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Phentolamine Mesylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Phentolamine Mesylate Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Phentolamine Mesylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Phentolamine Mesylate Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Phentolamine Mesylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Phentolamine Mesylate Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Phentolamine Mesylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Phentolamine Mesylate Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Phentolamine Mesylate Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Injection
  • Intramuscular Injection
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Hikma
  • Precision Dose
  • Septodont
  • Hainan Poly Pharm
  • CR Double-Crane
  • Sunflower Pharmaceutical
  • Shanghai Fudan Forward Pharmaceuticals
  • Sichuan Meida Kangjiale Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phentolamine Mesylate Injection Sales Value (2021-2032)
  4. 1.2.2 Global Phentolamine Mesylate Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Phentolamine Mesylate Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Phentolamine Mesylate Injection Market Dynamics
  1. 2.1 Phentolamine Mesylate Injection Industry Trends
  2. 2.2 Phentolamine Mesylate Injection Industry Drivers
  3. 2.3 Phentolamine Mesylate Injection Industry Opportunities and Challenges
  4. 2.4 Phentolamine Mesylate Injection Industry Restraints
3 Phentolamine Mesylate Injection Market by Company
  1. 3.1 Global Phentolamine Mesylate Injection Company Revenue Ranking in 2025
  2. 3.2 Global Phentolamine Mesylate Injection Revenue by Company (2021-2026)
  3. 3.3 Global Phentolamine Mesylate Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Phentolamine Mesylate Injection Average Price by Company (2021-2026)
  5. 3.5 Global Phentolamine Mesylate Injection Company Ranking (2024-2026)
  6. 3.6 Global Phentolamine Mesylate Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Phentolamine Mesylate Injection Company Product Type and Application
  8. 3.8 Global Phentolamine Mesylate Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Phentolamine Mesylate Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Phentolamine Mesylate Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Phentolamine Mesylate Injection Market by Type
  1. 4.1 Phentolamine Mesylate Injection Type Introduction
  2. 4.1.1 Intravenous Injection
  3. 4.1.2 Intramuscular Injection
  4. 4.2 Global Phentolamine Mesylate Injection Sales Volume by Type
  5. 4.2.1 Global Phentolamine Mesylate Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Phentolamine Mesylate Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Phentolamine Mesylate Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Phentolamine Mesylate Injection Sales Value by Type
  9. 4.3.1 Global Phentolamine Mesylate Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Phentolamine Mesylate Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Phentolamine Mesylate Injection Sales Value Share by Type (2021-2032)
5 Phentolamine Mesylate Injection Market by Application
  1. 5.1 Phentolamine Mesylate Injection Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Phentolamine Mesylate Injection Sales Volume by Application
  6. 5.2.1 Global Phentolamine Mesylate Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Phentolamine Mesylate Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Phentolamine Mesylate Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Phentolamine Mesylate Injection Sales Value by Application
  10. 5.3.1 Global Phentolamine Mesylate Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Phentolamine Mesylate Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Phentolamine Mesylate Injection Sales Value Share by Application (2021-2032)
6 Phentolamine Mesylate Injection Regional Sales and Value Analysis
  1. 6.1 Global Phentolamine Mesylate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Phentolamine Mesylate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Phentolamine Mesylate Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Phentolamine Mesylate Injection Sales by Region (2027-2032)
  5. 6.3 Global Phentolamine Mesylate Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Phentolamine Mesylate Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Phentolamine Mesylate Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Phentolamine Mesylate Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Phentolamine Mesylate Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Phentolamine Mesylate Injection Sales Value (2021-2032)
  12. 6.6.2 North America Phentolamine Mesylate Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Phentolamine Mesylate Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Phentolamine Mesylate Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Phentolamine Mesylate Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Phentolamine Mesylate Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Phentolamine Mesylate Injection Sales Value (2021-2032)
  21. 6.9.2 South America Phentolamine Mesylate Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Phentolamine Mesylate Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Phentolamine Mesylate Injection Sales Value Share by Country, 2025 VS 2032
7 Phentolamine Mesylate Injection Country-level Sales and Value Analysis
  1. 7.1 Global Phentolamine Mesylate Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Phentolamine Mesylate Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Phentolamine Mesylate Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Phentolamine Mesylate Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Phentolamine Mesylate Injection Sales by Country (2027-2032)
  6. 7.4 Global Phentolamine Mesylate Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Phentolamine Mesylate Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Phentolamine Mesylate Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Phentolamine Mesylate Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Phentolamine Mesylate Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Phentolamine Mesylate Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hikma
  2. 8.1.1 Hikma Company Information
  3. 8.1.2 Hikma Business Overview
  4. 8.1.3 Hikma Phentolamine Mesylate Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hikma Phentolamine Mesylate Injection Product Portfolio
  6. 8.1.5 Hikma Recent Developments
  7. 8.2 Precision Dose
  8. 8.2.1 Precision Dose Company Information
  9. 8.2.2 Precision Dose Business Overview
  10. 8.2.3 Precision Dose Phentolamine Mesylate Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Precision Dose Phentolamine Mesylate Injection Product Portfolio
  12. 8.2.5 Precision Dose Recent Developments
  13. 8.3 Septodont
  14. 8.3.1 Septodont Company Information
  15. 8.3.2 Septodont Business Overview
  16. 8.3.3 Septodont Phentolamine Mesylate Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Septodont Phentolamine Mesylate Injection Product Portfolio
  18. 8.3.5 Septodont Recent Developments
  19. 8.4 Hainan Poly Pharm
  20. 8.4.1 Hainan Poly Pharm Company Information
  21. 8.4.2 Hainan Poly Pharm Business Overview
  22. 8.4.3 Hainan Poly Pharm Phentolamine Mesylate Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolio
  24. 8.4.5 Hainan Poly Pharm Recent Developments
  25. 8.5 CR Double-Crane
  26. 8.5.1 CR Double-Crane Company Information
  27. 8.5.2 CR Double-Crane Business Overview
  28. 8.5.3 CR Double-Crane Phentolamine Mesylate Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CR Double-Crane Phentolamine Mesylate Injection Product Portfolio
  30. 8.5.5 CR Double-Crane Recent Developments
  31. 8.6 Sunflower Pharmaceutical
  32. 8.6.1 Sunflower Pharmaceutical Company Information
  33. 8.6.2 Sunflower Pharmaceutical Business Overview
  34. 8.6.3 Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolio
  36. 8.6.5 Sunflower Pharmaceutical Recent Developments
  37. 8.7 Shanghai Fudan Forward Pharmaceuticals
  38. 8.7.1 Shanghai Fudan Forward Pharmaceuticals Company Information
  39. 8.7.2 Shanghai Fudan Forward Pharmaceuticals Business Overview
  40. 8.7.3 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolio
  42. 8.7.5 Shanghai Fudan Forward Pharmaceuticals Recent Developments
  43. 8.8 Sichuan Meida Kangjiale Pharmaceutical
  44. 8.8.1 Sichuan Meida Kangjiale Pharmaceutical Company Information
  45. 8.8.2 Sichuan Meida Kangjiale Pharmaceutical Business Overview
  46. 8.8.3 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolio
  48. 8.8.5 Sichuan Meida Kangjiale Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Phentolamine Mesylate Injection Value Chain Analysis
  2. 9.1.1 Phentolamine Mesylate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Phentolamine Mesylate Injection Sales Mode & Process
  6. 9.2 Phentolamine Mesylate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Phentolamine Mesylate Injection Distributors
  9. 9.2.3 Phentolamine Mesylate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst